Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Accumulated Expenses (2021 - 2026)

Abpro Holdings' (ABPO) quarterly Accumulated Expenses came in at $3.9 million in Q1 2026, down 50.23% YoY from $7.8 million in Q1 2025, and little changed on a QoQ basis from $3.9 million in Q4 2025.

Abpro Holdings (ABPO) Accumulated Expenses (2021 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 6 years of Accumulated Expenses data on file, last reported at $3.9 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 50.23% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 50.23% YoY) and the FY2025 annual result came in at $3.9 million, down 48.31% from the prior year.
  • Accumulated Expenses held at $3.9 million in Q1 2026, from $3.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $8.0 million in Q3 2025 to a low of $200000.0 in Q2 2024.
  • A 5-year average of $3.6 million and a median of $2.8 million in 2023 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses surged 289749.41% — and 2024, when it slumped 88.86%.
  • Tracing ABPO's Accumulated Expenses over 5 years: stood at $5.2 million in 2022, then sank by 73.1% to $1.4 million in 2023, then jumped by 436.19% to $7.5 million in 2024, then slumped by 48.31% to $3.9 million in 2025, then dropped by 0.1% to $3.9 million in 2026.
  • The last three Accumulated Expenses figures came in at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Abpro Holdings 1.14 Mn 1.14 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.87 Mn
Dec 31, 2025 3.88 Mn
Sep 30, 2025 8.03 Mn
Jun 30, 2025 8.02 Mn
Mar 31, 2025 7.78 Mn
Dec 31, 2024 7.50 Mn
Sep 30, 2024 6.05 Mn
Jun 30, 2024 200,000.00
Dec 31, 2023 1.40 Mn
Sep 30, 2023 715,146.00
Jun 30, 2023 1.80 Mn
Mar 31, 2023 1.58 Mn
Dec 31, 2022 5.20 Mn
Sep 30, 2022 895,709.00
Jun 30, 2022 576,758.00
Mar 31, 2022 303,037.00
Dec 31, 2021 1,793.00